This Ingredients Catechins From Green Tea May Slow The Progression Of Prostate Cancer Part 1

Prostate  cancer is the second most common cancer in men, responsible for an estimated 220,000 cancer diagnoses in 2015 alone. Recent cancer research has focused on the possible role botanicals might play in the prevention and treatment of cancer. Researchers at Moffitt Cancer Center conducted a randomized trial to determine the safety and efficacy of green tea catechins in preventing the progression of prostate cancer in men with premalignant lesions.

Green Tea’s Impressive Reputation

Green tea as a possible cancer preventative isn’t new news. We know that 20% of green tea is consumed in Asian countries that boast remarkably low death rates from prostate cancer. We also know that prostate cancer risk increases greatly among Asian men who settle in the United States and forego their green tea drinking habits.

Lab studies show that active compounds called catechins in green tea help to suppress cancer cell growth, motility, and invasion, and trigger cancer cell death. Animal models confirm the cancer-protective benefits of green tea catechins, which help to prevent tumors and stall tumor growth.

Epigallocatechin-3-gallate (EGCG)s the primary catechin in green tea, and is credited with its cancer-fighting powers.